|
|
News Breaks | | | | February 22, 2013 | | 07:52 EDT |  | SNY | EMA gives positive recommendations for Sanofi's Hexacima, Hexyon The Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Hexacima, 0.5 ml, suspension for injection intended for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type b. The Committee also adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Hexyon, 0.5 ml, suspension for injection intended for primary and booster vaccination of infants and toddlers from six weeks to 24 months of age against the same diseases. The applicant for these medicinal products is Sanofi Pasteur. | |
|
News For SNY From The Last 14 Days Check below for free stories on SNY the last two weeks. |
|
|
| May 23, 2013 | | 08:18 EDT |  | SNY | Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
Subscribe for More Information | | | May 21, 2013 | | 07:44 EDT |  | SNY | Sachs Associates to host a forum
Subscribe for More Information | | | May 20, 2013 | | 17:26 EDT |  | SNY | Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information | | | 11:27 EDT |  | SNY | Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva
Subscribe for More Information | | | May 17, 2013 | | 08:03 EDT |  | SNY | Sanofi reports positive topline results from pivotal Phase III Jakarta study
Subscribe for More Information | | | 05:18 EDT |  | SNY | Sanofi says JAK2 inhibitor for myelofibrosis met primary endpoint
Subscribe for More Information | | | May 15, 2013 | | 15:16 EDT |  | SNY | Sanofi systemic sclerosis treatment designated for orphan drug status
Subscribe for More Information | | | 05:39 EDT |  | SNY | Sanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information | | | May 13, 2013 | | 09:44 EDT |  | SNY | Several companies reportedly interested in buying Adcock Ingram, Globes says
Subscribe for More Information | | | 07:30 EDT |  | SNY | TechConnect to host a summit 2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. | | |
|
|
|
|
|
|